-
Certain beta-blockers may reduce Alzheimer's risk
Time of Update: 2022-06-06
Molano, MD Hypertensive patients taking blood-brain barrier permeability comparison The risk of Alzheimer's disease is lower with high beta-blockers than with less penetrant beta-blockers .
-
Stroke: Association between beta-blocker or statin use and risk of cavernous malformation bleeding
Time of Update: 2022-05-23
The researchers found that beta-blocker use was associated with a lower risk of new intracranial hemorrhage or persistent/progressive focal neurological deficit (adjusted hazard ratio, 0.
-
GUT: Beta blockers improve clinical outcomes by improving systemic inflammation in patients with advanced chronic liver disease
Time of Update: 2021-09-03
In addition, the markers of high systemic inflammation in patients with advanced liver cirrhosis will be significantly increased (for example, white blood cell count (WBC), plasma C-reactive protein (CRP), pro-inflammatory cytokines, such as interleukin 6 (IL-6) and Procalcitonin (PCT) .
-
Detection of Beta-Blockers in Urine and Serum by Solid-Phase Extraction-Supercritical Fluid Extraction and Gas Chromatography-Mass Spectrometry
Time of Update: 2021-03-05
Beta-blockers have some clinical use in the treatment of angina pectoris, hypertension, and tachycardia. In addition, they have been used to control migraine, chronic alcoholism, schizophrenia, essential tremor, and cardiac effects
-
"BETA" principle: How coronary heart disease patients use beta blockers
Time of Update: 2020-05-29
beta blockers have been shown to reduce the risk of all-cause dying and cardiovascular death in patients with non-contraindication-free coronary heart disease. Authoritative guidelines at home and abroad consistently recommend
